An Analysis of Relapse Rates and Predictors of Relapse in 2 Randomized, Placebo-Controlled Trials of Desvenlafaxine for Major Depressive Disorder
Author(s) -
Roger S. McIntyre,
Rana Fayyad,
Christine J. GuicoPabia,
Matthieu Boucher
Publication year - 2015
Publication title -
the primary care companion for cns disorders
Language(s) - English
Resource type - Journals
eISSN - 2155-7772
pISSN - 2155-7780
DOI - 10.4088/pcc.14m01681
Subject(s) - placebo , medicine , hazard ratio , major depressive disorder , proportional hazards model , psychiatry , confidence interval , alternative medicine , pathology , amygdala
To evaluate relapse rates and predictors of relapse in 2 randomized, placebo-controlled trials of desvenlafaxine for major depressive disorder (MDD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom